Hainan Poly Pharm Balance Sheet Health
Financial Health criteria checks 3/6
Hainan Poly Pharm has a total shareholder equity of CN¥3.1B and total debt of CN¥2.6B, which brings its debt-to-equity ratio to 83.6%. Its total assets and total liabilities are CN¥6.7B and CN¥3.5B respectively. Hainan Poly Pharm's EBIT is CN¥300.2M making its interest coverage ratio -100.7. It has cash and short-term investments of CN¥447.6M.
Key information
83.6%
Debt to equity ratio
CN¥2.63b
Debt
Interest coverage ratio | -100.7x |
Cash | CN¥447.58m |
Equity | CN¥3.14b |
Total liabilities | CN¥3.54b |
Total assets | CN¥6.69b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300630's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 300630's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 300630's net debt to equity ratio (69.4%) is considered high.
Reducing Debt: 300630's debt to equity ratio has increased from 5.2% to 83.6% over the past 5 years.
Debt Coverage: 300630's debt is not well covered by operating cash flow (18.4%).
Interest Coverage: 300630 earns more interest than it pays, so coverage of interest payments is not a concern.